GIP and type 2 diabetes mellitus: For this purpose, a list of keywords to identify the eligible studies was prepared which included Tirzepatide, LY3298176, oral, dual agonist, twincretin, GLP-1, GIP, T2DM, T2DM, clinical, systematic review, meta-analysis.